Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TScan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 47.5K | Jun 12, 2024 | Direct | ||
Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 12.5K | May 5, 2023 | Direct | ||
Molecular Templates, Inc. | Director | Stock Option (right to buy) | 1K | Sep 27, 2024 | Direct |